Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
terbinafine hydrochloride | Tablet, uncoated | 281.25 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
calcitonin salmon | Injection, solution | 100 IU/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 27/06/2025 |
lamotrigine | Tablet, chewable | 100 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
bicalutamide | Tablet, film coated | 50 mg | Anticipated | Available | Unexpected increase in consumer demand | 27/06/2025 |
hydrocortisone sodium succinate | Injection, powder for | 134 mg | Resolved | Available | Unexpected increase in consumer demand | 27/06/2025 |
pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
candesartan cilexetil | Tablet, uncoated | 16 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
quetiapine fumarate | Tablet, modified release | 460.52 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
clopidogrel besilate | Tablet, film coated | 112.1 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
nicorandil | Tablet | 20 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
neostigmine methylsulfate | Injection, solution | 2.5 mg | Resolved | Available | Manufacturing | 27/06/2025 |
pemetrexed disodium | Injection, powder for | 1102.9 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
rifampicin | Capsule | 300 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
irbesartan | Tablet, film coated | 300 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
flucloxacillin sodium monohydrate | Injection, powder for | 544.1 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 27/06/2025 |
lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
flecainide acetate | Tablet | 50 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
methylphenidate hydrochloride | Capsule, hard | 40 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 27/06/2025 |
paracetamol | Tablet, modified release | 665 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 27/06/2025 |
tirzepatide | Injection, solution | 5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
tirzepatide | Injection, solution | 7.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
tirzepatide | Injection, solution | 12.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
tirzepatide | Injection, solution | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
tirzepatide | Injection, solution | 15 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
tirzepatide | Injection, solution | 2.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
rifampicin | Capsule, hard | 300 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
rifabutin | Capsule, hard | 150 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
propofol | Injection, emulsion | 10 mg/mL | Current | Unavailable | Manufacturing | 27/06/2025 |
ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
Equine antithymocyte immunoglobulin | Injection, solution | 50 mg/mL | Anticipated | Available | Manufacturing | 26/06/2025 |
sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 26/06/2025 |
dopamine hydrochloride | Injection, concentrated | 40 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 26/06/2025 |
omeprazole magnesium | Tablet, enteric coated | 20.6 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 26/06/2025 |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 26/06/2025 |
Follitropin alfa | Injection, solution | 150 IU | Current | Unavailable | Manufacturing | 26/06/2025 |
fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 26/06/2025 |
lidocaine hydrochloride | Injection, solution | 400 mg | Discontinued | Unavailable | Manufacturing | 26/06/2025 |
methylphenidate hydrochloride | Capsule, hard | 20 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 26/06/2025 |
methylphenidate hydrochloride | Capsule, hard | 60 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 26/06/2025 |
mirtazapine | Tablet, film coated | 30 mg | Anticipated | Available | Manufacturing | 26/06/2025 |
albendazole | Tablet, chewable | 400 mg | Current | Unavailable | Manufacturing | 26/06/2025 |
verapamil hydrochloride | Tablet, modified release | 240 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Resolved | Available | Manufacturing | 25/06/2025 |
amiodarone hydrochloride | Injection, solution | 150 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 25/06/2025 |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 25/06/2025 |
aripiprazole | Tablet, uncoated | 10 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
indapamide hemihydrate~perindopril erbumine | Tablet | 1.25 mg~4 mg | Anticipated | Available | Manufacturing | 25/06/2025 |
risperidone | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
esomeprazole | Capsule, enteric | 20 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
solifenacin succinate | Tablet | 5 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 25/06/2025 |
busulfan | Injection, concentrated | 60 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~20.681 mg | Resolved | Available | Manufacturing | 25/06/2025 |
dorzolamide hydrochloride~timolol maleate | Eye Drops, solution | 22.26 mg/mL~6.83 mg/mL | Current | Limited Availability | Manufacturing | 25/06/2025 |
bortezomib | Injection, solution | 3.5 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
levothyroxine sodium | Tablet, uncoated | .05 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
levothyroxine sodium | Tablet, uncoated | .075 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
azithromycin dihydrate | Tablet, film coated | 524 mg | Resolved | Available | Unexpected increase in consumer demand | 25/06/2025 |
sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, film coated | 56.69 mg~500 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, film coated | 850 mg~56.69 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, film coated | 1000 mg~56.69 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
sodium amidotrizoate~amidotrizoate meglumine | Injection, solution | 40 mg/mL~260 mg/mL | Resolved | Available | Manufacturing | 25/06/2025 |
antimony trisulfide | Injection, solution | 1.1 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 25/06/2025 |
omeprazole | Capsule | 20 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 25/06/2025 |
tiagabine hydrochloride monohydrate | Tablet, film coated | 5.73 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 24/06/2025 |
tiagabine hydrochloride monohydrate | Tablet, film coated | 11.5 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 24/06/2025 |
tiagabine hydrochloride monohydrate | Tablet, film coated | 17.2 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 24/06/2025 |
zolpidem tartrate | Tablet, film coated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 24/06/2025 |
midazolam | Injection, solution | 5 mg/mL | Anticipated | Available | Manufacturing | 24/06/2025 |
risperidone | Tablet, film coated | 2 mg | Anticipated | Available | Manufacturing | 24/06/2025 |
hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Resolved | Available | Manufacturing | 24/06/2025 |
ropivacaine hydrochloride | Injection, solution | 150 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 24/06/2025 |
quetiapine fumarate | Tablet, modified release | 57.565 mg | Current | Limited Availability | Unexpected increase in consumer demand | 24/06/2025 |
quetiapine fumarate | Tablet, modified release | 172.695 mg | Resolved | Available | Unexpected increase in consumer demand | 24/06/2025 |
paclitaxel | Injection, concentrated | 300 mg | Anticipated | Available | Manufacturing | 24/06/2025 |
rifampicin | Capsule | 150 mg | Anticipated | Available | Manufacturing | 24/06/2025 |
armodafinil | Tablet, uncoated | 50 mg | Resolved | Available | Manufacturing | 24/06/2025 |
metformin hydrochloride | Tablet, film coated | 500 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 24/06/2025 |
moxonidine | Tablet, film coated | 200 microgram | Resolved | Available | Manufacturing | 24/06/2025 |
rivaroxaban | Tablet, film coated | 2.5 mg | Resolved | Available | Unexpected increase in consumer demand | 24/06/2025 |
rivaroxaban | Tablet, film coated | 10 mg | Resolved | Available | Unexpected increase in consumer demand | 24/06/2025 |
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) | Injection, powder for | 200000000 CFU | Current | Unavailable | Manufacturing | 24/06/2025 |
estradiol hemihydrate | Drug delivery system, transdermal | 2.32 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/06/2025 |
lidocaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 23/06/2025 |
olanzapine | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 23/06/2025 |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Resolved | Available | Manufacturing | 23/06/2025 |
prucalopride succinate | Tablet, film coated | 2.642 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 23/06/2025 |
galantamine hydrobromide | Capsule, modified release | 30.756 mg | Anticipated | Available | Manufacturing | 23/06/2025 |
montelukast sodium | Tablet, chewable | 4.16 mg | Current | Limited Availability | Manufacturing | 23/06/2025 |
lansoprazole | Tablet, orally disintegrating | 15 mg | Resolved | Available | Manufacturing | 23/06/2025 |
isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
candesartan cilexetil | Tablet, uncoated | 32 mg | Current | Limited Availability | Manufacturing | 23/06/2025 |
pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Unexpected increase in consumer demand | 23/06/2025 |
linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
clonidine hydrochloride | Tablet | 100 microgram | Current | Unavailable | Unexpected increase in consumer demand | 23/06/2025 |
hydromorphone hydrochloride | Injection, solution | 2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/06/2025 |
hydromorphone hydrochloride | Injection, solution | 10 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/06/2025 |
nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
fenofibrate | Tablet | 145 mg | Resolved | Available | Manufacturing | 23/06/2025 |
mupirocin calcium | Ointment | 21.5 mg/g | Anticipated | Available | Manufacturing | 23/06/2025 |
Semaglutide | Injection, solution | 1.34 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/06/2025 |
Semaglutide | Injection, solution | 1.34 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 23/06/2025 |
levothyroxine sodium | Tablet | .2 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
isoprenaline hydrochloride | Injection, solution | 1 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
Semaglutide | Injection, solution | .68 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 23/06/2025 |
lidocaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 23/06/2025 |
Measles virus~Mumps virus~Rubella virus | Injection, powder for | 1000 CCID50~5000 CCID50~1000 CCID50 | Current | Limited Availability | Unexpected increase in consumer demand | 23/06/2025 |